体内精原干细胞转染法建立转基因小鼠

将人Bcl-2 cDNA与小鼠乳清酸蛋白(WAP)5’上游调控序列融合后,与脂质体按一定比例混合,再加入适量的台盼蓝制成转染液,注入到小鼠睾丸中的曲细精管中,转染精原干细胞以探讨建立转基因小鼠的可行性。共注射了3只公鼠,4天后将公鼠与发情母鼠合笼交配,共生仔鼠20只。检测结果表明,有3只呈PCR阳性,Southern blot检测,阳性鼠2只,1只公鼠,1只母鼠,其中,公鼠意外死亡;Western blot证实,1只母鼠的乳腺组织表达了Bcl-2蛋白,其F1代的16只小鼠中,有7只呈PCR阳性。证实了体内精原干细胞转染建立转基因动物的可行性。     

利用精原干细胞法生产转基因动物的研究进展

综述了利用精原干细胞生产转基因动物的发展历程、方法以及最新研究进展.重点从精原干细胞移植法和曲细精管微注射法两个方面,系统分析了利用精原干细胞生产转基因动物的优缺点,以及当前存在的问题.     

精原干细胞途径制作转基因动物

精原干细胞(spermatogonial stem cells,SSCS)具自我更新并分化出大量精子的能力.通过其建立转基因动物模型,对研究精子的发生机制、生产转基因动物、重建不育个体的生精功能等都有着.显著的推动作用.从研究意义着手,分述了精原干细胞途径制作转基因动物各技术步骤的研究情况,并提出了运用克隆技术丰富该途径的新思路.     

小鼠精原干细胞不同转染方法效率的比较

本研究采用腺病毒感染、慢病毒感染、脂质体转染和电穿孔转化方法将含有绿色荧光蛋白（GFP）的质粒转入经过差异贴壁法初步分离纯化的小鼠精原干细胞(SSCs)中,转染48 h后通过流式细胞仪检测GFP阳性细胞比例比较4种方法在体外转染精原干细胞的效率.结果显示,脂质体转染效率最高仅为8.64%,不能满足对精原干细胞进一步实验的要求;电穿孔法效率最高达到25.27%,但转化后细胞大量死亡;腺病毒转染细胞的效率达到了32.4%;慢病毒转染效率最高,达到74.25%. 因此,慢病毒转染法是体外转染小鼠精原干细胞的有效方法.     

精原干细胞移植受体鼠模型的建立

目的 通过对4周龄昆明白小鼠腹腔内单次注射白消安来制作精原干细胞移植受体鼠模型。方法 将实验动物分为4组,A、B、C组注射白消安的剂量分别是30 mg/kg4、0 mg/kg5、0 mg/kg体重,D组为对照组。注射后每天记录小鼠的存活情况,注射白消安后的20 d3、0 d4、0 d称量睾丸重量、测定血常规、制作并观察睾丸组织学切片、统计曲细精管的中空率。结果 A、B、C、D组的死亡率分别是25.00%3、1.58%、80.00%、0.00%,注射白消安后30 d各组小鼠曲细精管中空率分别是45.25%、75.25%、1.50%、0.00%,白细胞、红细胞、血小板数量等血常规指标均恢复正常。结论 腹腔内单次注射30 mg/kg或40 mg/kg剂量的白消安,死亡率较低（25.00%、31.58%）,30 d后曲细精管中空率较高（45.25%7、5.25%）、血常规指标恢复正常,适合做精原干细胞移植受体。     

体内外精原干细胞介导大群生产转基因鸡

本研究以重组的绿色荧光蛋白基因为标记,采用公鸡睾丸内转染精原干细胞（spermatogonial stem cells,SSCs）和体外转染SSCs再移植的方法,探索家禽转基因新方法．同时比较了公鸡接受不同剂量外源基因的转基因效率．结果显示：（i）接受外源基因剂量分别为50,100,150和200μg／mL时,48h后睾丸细胞显示绿色荧光的比率分别为4．0％,8．7％,10．2％和13．6％,差异显著（P〈0．05）．睾丸内注射外源基因第25天后,随着时间的增长,精子表达绿色荧光的百分率逐渐提高,到第70天后表达率达到高峰,且趋于稳定,4个剂量组分别为12．7％,12．8％,15．9％和19．1％．差异显著（P〈0．05）;（ii）第70天的睾丸冰冻切片观察,曲精细管周边均有荧光表达;（iii）F1代中,56．2％（254／452）的胚盘表达绿色荧光．活鸡血样PCR检测56．5％（13／23）为阳性,Southern blot检测证明外源基因已整合到鸡基因组;F2代中,53．2％（275／517）的胚盘表达绿色荧光．活鸡血样PCR检测52．9％（9／17）为阳性;（iv）F,代和F2代鸡心、肝、肾和肌肉等组织冰冻切片观察和PCR检测,绿色荧光阳性率在50．0％～66．7％之间;（v）体外SSCs转染外源基因后移植,可在受体公鸡睾丸中生长发育,正常产生精子．后代中,12．5％（8／64）的胚盘表达绿色荧光,活鸡血样PCR检测11．1％（2／18）为阳性．结果证明精原干细胞介导转基因是一种简单、高效、可大群体生产转基因鸡的有效途径．     

不同年龄小鼠精原干细胞系的建立

精原干细胞（spennatogonial stem cells,SSCs）是雄性动物体内能进行终生自我更新并能将亲代基因遗传给予子代的一类细胞。不同年龄段的小鼠有不同的建系方法。6-7d幼鼠,可以用差异贴壁或直接贴壁法;5-6周成年鼠,一般采用差异贴壁法;31周老年鼠,最好种于饲养层细胞上。通过对精原干细胞系的甲基化和特异基因分析以及睾丸体内移植验证分析,成功建立了具有功能的不同年龄段的小鼠精原干细胞系。     

小鼠精原干细胞冻存后体外培养

目的:研究冷冻后精原干细胞体外培养时的生物学行为.方法:体外培养冻存后的6日龄小鼠生精上皮细胞,并利用碱性磷酸酶活性及细胞形态,检测其中的精原干细胞.结果:当有BRL饲养层时,冻存后的精原细胞在贴壁、存活及增殖等生物学行为方面与新分离的精原细胞均无明显不同.培养25～30 d,培养体系中仍保留有少量精原干细胞及其最初几代分化细胞.结论:冷冻保存后的精原干细胞能在BRL细胞饲养层上正常地贴壁、生长和分裂.     

人尿激酶原乳腺定位转基因小鼠的建立

应用大鼠β乳酪蛋白基因的上游调控序列和人尿激酶原ｃＤＮＡ构建成功了乳腺定位表达载体．用显微注射的手段导入到受精卵的雄前核,从注射的３００枚受精卵中,１４０枚被移植到９只假孕的受体小鼠．结果从获得的子一代小鼠中,经ＰＣＲ和Ｓｏｕｔｈｅｒｎｂｌｏｔ证实,有３只转基因阳性的小鼠．     

Production of transgenic mice carrying the Thanatin gene by intratesticular injection

Transgenic animals have potential applications in medicine, life sciences, and biopharmacy. In this study, we developed a convenient, economic, and efficient method for gene transfer by transfection of male spermatogonial stem cells. Three fragments of the Thanatin gene, encoding an antibacterial peptide, were synthesized and amplified by overlap extension polymerase chain reaction (PCR). They were inserted into vector pIRES2-EGFP. The pIRES2-EGFP-Thanatin plasmid was mixed with liposomes and injected into the testes of male mice by a minimally invasive operation. Six weeks after injection, male mice were mated with normal female mice to produce an F1 generation. PCR and Southern blotting were performed to analyze F1 mice. Among those 52 F1 mice produced, 38.46% were found to be positive for the Thanatin gene by PCR and 30.77% by Southern blotting. Six positive mice were selected from the F1 generation and mated with normal females to an F2 generation, in which 36.36% were found to be positive for the Thanatin gene. Expression of the green fluorescence protein in the transgenic mice was confirmed by fluorescence imaging. These results showed that the Thanatin gene was integrated into the mouse genome. The study provides a useful method for the future development of disease-resistant animals and production of antibacterial peptides through transgenic animals.     

Production of transgenic mice expressing the goat H-FABP gene by intratesticular injection

The objective of this study was to explore the possibility of obtaining stable transgenic animals by intratesticular injection. The recombinant vector pEGFP-H-FABP expressing the goat heart-type fatty acid binding protein and green fluorescent protein was mixed with liposome complexes and randomly injected into the testes of mice. Testicular section, fluorescence, and DNA detection assays of mouse sperm were performed to determine the integration of foreign DNA. The results showed that foreign DNA was successfully expressed in the treated mice. Furthermore, the expression and function of the foreign gene were analyzed in F₁ generation and F₂ generation mice at different levels, with the positive rates of foreign gene transfer into the F₁ and F₂ generations being 4.0 and 30.23 %, respectively. These results strongly support testicular injection as an effective method of producing transgenic animals and indicate that foreign genes can be stably passed on to the offspring. This research has theoretical and practical implications for the improvement in the quality of laboratory animals and for gene therapy.     

Production of transgenic mice

A “transgenic” mouse is identified by the integration of a foreign DNA into its genome. Such animals serve as experimental systems for the study of gene expression and are often generated as models for human diseases. Direct microinjection of DNA into the male pronucleus of a mouse zygote has been the method most extensively used in the production of transgenic mice. Our method is subdivided into three sections: First, Preinjection, where the animals, the donor eggs, and the injection tools are presented. Second, Injection, where the egg handling and micromanipulation is described. Third, Postinjection, where the surgical transfer into pseudopregnant females completes the procedural sequence. Additional sections are provided to include the materials we use and to offer a series of technical tips that cover various aspects of the transgenic process.     

Production of transgenic porcine blastocysts by nuclear transfer

In this study the in vitro development of porcine nuclear transfer (NT) embryos was investigated. Transgenic fetal fibroblast cells that were frozen after 5 days of serum starvation were injected immediately after thawing into enucleated metaphase II (MII) oocytes. Reconstructed embryos were activated by incubation in 200 microM thimerosal followed by a 30-min treatment of 8 mM DTT. The embryos were subsequently cultured in NCSU23, supplemented with 4 mg/ml BSA for 7 days. The actual cleavage rate (embryos showing > or =2 nuclei) in 6 replicates was 33% (ranging from 15% to 50%). Three blastocysts with cell numbers of 14, 15, and 18 were obtained. The blastocyst rate was significantly lower for NT embryos as opposed to parthenogenetically activated embryos (1% vs. 5%; P<0.05). The neomycin-resistance gene was amplified by PCR in all three NT embryos, indicating their origin from the injected transgenic fibroblasts. Efforts are now being directed in improvements in the nuclear transfer technology, whereby viable fetuses or offspring can be produced from these NT-embryos.     

Effective generation of transgenic pigs and mice by linker based sperm-mediated gene transfer.

Background

Transgenic animals have become valuable tools for both research and applied purposes. The current method of gene transfer, microinjection, which is widely used in transgenic mouse production, has only had limited success in producing transgenic animals of larger or higher species. Here, we report a linker based sperm-mediated gene transfer method (LB-SMGT) that greatly improves the production efficiency of large transgenic animals.

Results

The linker protein, a monoclonal antibody (mAb C), is reactive to a surface antigen on sperm of all tested species including pig, mouse, chicken, cow, goat, sheep, and human. mAb C is a basic protein that binds to DNA through ionic interaction allowing exogenous DNA to be linked specifically to sperm. After fertilization of the egg, the DNA is shown to be successfully integrated into the genome of viable pig and mouse offspring with germ-line transfer to the F1 generation at a highly efficient rate: 37.5% of pigs and 33% of mice. The integration is demonstrated again by FISH analysis and F2 transmission in pigs. Furthermore, expression of the transgene is demonstrated in 61% (35/57) of transgenic pigs (F0 generation).

Conclusions

Our data suggests that LB-SMGT could be used to generate transgenic animals efficiently in many different species.     

Treatment of experimental liver tumors by in vivo suicide gene transfer in rats]

We investigated whether the transduction of a suicide gene might induce the elimination of malignant solid tumours. BDIX male rats were given an intra-hepatic injection of a mixture containing DHDK12 tumor cells and xenogeneic fibroblasts. The latter were producing either the herpes simplex virus type 1 thymidine kinase HSV1-TK- or nls-lac Z(control)-expressing recombinant retroviral particles. 5 days later, a time at which the tumor is macroscopic, all the rats were treated with ganciclovir, a nucleoside analog that is metabolized by HSV1-TK into a toxic compound. After 5 days of treatment, a dramatic reduction in tumour volume was noted in the HSV1-TK group. These results delineate a new therapeutical strategy for the treatment of disseminated liver metastases or of a large variety of solid malignant tumours.     

Production and characterization of transgenic mice harboring mutant human UMOD gene

Familial juvenile hyperuricemic nephropathy is caused by mutations in the UMOD gene encoding uromodulin. A transgenic mouse model was developed by introducing a human mutant UMOD (C148W) cDNA under control of the mouse umod promoter. Uromodulin accumulation was observed in the thick ascending limb cells in the kidney of transgenic mice. However, the urinary excretion of uromodulin in transgenic mice did not decrease and LC-MS/MS analysis indicated it was of mouse origin. Moreover, the creatinine clearance was not different between wildtype and transgenic animals. Consequently, the onset of the disease was not observed in transgenic mice until 24 weeks of age.     

Production of functional transgenic mice by DNA pronuclear microinjection

Successful experiments involving the production of transgenic mice by pronuclear microinjection are currently limited by low efficiency of random transgene integration into the mouse genome. Furthermore, not all transgenic mice express integrated transgenes, or in other words are effective as functional transgenic mice expressing the desired product of the transgene, thus allowing accomplishment of the ultimate experimental goal - in vivo analysis of the function of the gene or gene network. The purpose of this review is to look at the current state of transgenic technology, utilizing a pronuclear microinjection method as the most accepted way of gene transfer into the mouse genome.